IMDX
Insight Molecular Diagnostics Inc. · Healthcare · Market cap $135.5M
Insiders bought $2.7M net in the last 90 days ·0 sellers, 1 buyer· latest Form 4 filed Apr 27, 2026
Insider Buying
$5.7M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Latest filing
Jul 7, 2026
BROADWOOD PARTNERS, L.P.
Insight Molecular Diagnostics Inc. (IMDX) has 14 SEC Form 4 filings (22 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jul 7, 2026.
Inside the rolling window, 1 insider at Insight Molecular Diagnostics Inc. reported 7 open-market purchases totaling $5.7M and no open-market sales. The most active filer is 10% Owner BROADWOOD PARTNERS, L.P. with 7 filings. Insiders have net bought $5.7M over the trailing 6 months. The largest single insider purchase in this window was $3.0M by 10% Owner BROADWOOD PARTNERS, L.P. on Feb 10, 2026. The most recent open-market filing is a purchase of 280,381 shares by 10% Owner BROADWOOD PARTNERS, L.P., dated Apr 23, 2026, worth $982K.
- Industry:Medical - Diagnostics & Research
- CEO:Joshua Riggs
- Employees:57
- HQ:Nashville, TN, US
- IPO:2015-12-30
| Source | |||||||
|---|---|---|---|---|---|---|---|
| 10% Owner | Purchase | 280,381 | $982K | Apr 27 | +7.8% | SEC ↗ | |
| 10% Owner | Purchase | 38,880 | $137K | Apr 27 | +7.8% | SEC ↗ | |
| 10% Owner | Purchase | 250,923 | $913K | Apr 27 | +7.8% | SEC ↗ | |
| 10% Owner | Purchase | 102,057 | $352K | Apr 20 | +3.8% | SEC ↗ | |
| 10% Owner | Purchase | 40,114 | $143K | Apr 20 | +3.8% | SEC ↗ | |
| 10% Owner | Purchase | 40,690 | $158K | Apr 20 | +3.8% | SEC ↗ | |
| 10% Owner | Purchase | 521,739 | $3.0M | Feb 12 | -25.8% | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does IMDX have?
Insight Molecular Diagnostics Inc. (IMDX) has 14 SEC Form 4 filings (22 transaction rows) in the rolling 365-day window, disclosed by 1 distinct insider. Most recent filing: Jul 7, 2026.
When was the most recent SEC Form 4 filing for IMDX?
The most recent Form 4 filing for IMDX on Tracefour is dated Jul 7, 2026.
Who is the most active insider at IMDX?
The most active SEC Form 4 filer at IMDX in the rolling window is 10% Owner BROADWOOD PARTNERS, L.P., with 7 filings.
What is the net insider flow at IMDX over the last 6 months?
Over the trailing 180 days, insiders at IMDX have net bought $5.7M based on SEC Form 4 disclosures.
What was the largest insider purchase at IMDX?
The largest single insider open-market purchase at IMDX in the rolling window was $3.0M by 10% Owner BROADWOOD PARTNERS, L.P. on 2026-02-10.
What is the total insider buy and sell value at IMDX in the current window?
Inside the rolling window, insiders at IMDX bought $5.7M and sold $0 based on SEC Form 4 filings.
Can I get alerts for IMDX insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Insight Molecular Diagnostics Inc. (IMDX). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Insight Molecular Diagnostics Inc. is in the Healthcare sector.